Loading chat...
HI HB661
Bill
Status
1/23/2017
Primary Sponsor
Marcus Oshiro
Click for details
AI Summary
-
Limits tetrahydrocannabinol (THC) potency in manufactured marijuana products to no more than 12 percent.
-
Requires warning labels on packaging of manufactured marijuana products stating "WARNING: THE HEALTH IMPACTS OF MARIJUANA WITH THC POTENCY LEVELS OF 10 PERCENT AND OVER ARE UNKNOWN" in bold capital letters at least 14-point font.
-
Maintains existing requirement that capsules, lozenges, or pills contain no more than 10 milligrams of THC per dose and no more than 100 milligrams total per container.
-
Addresses concerns raised by a task force minority regarding adolescent brain development, fetal exposure, marijuana-impaired driving, and unregulated product potency and dosage information.
Legislative Description
Relating To Medical Marijuana.
Medical Marijuana
Last Action
Re-referred to HHS, FIN, referral sheet 1
1/17/2018